Galderma has kicked off an ad campaign to show how its Nemluvio can empower people to rule over itchy eczema. Aiming to grow the biologic into a $2 billion product, the company is running ads ...

Low-dose doxycycline proved to be equally as effective as high-dose doxycycline for the treatment of scarring alopecia, with fewer adverse events, according to a study. However, high doses of ...

adding that Emrosi is the first new oral treatment for the condition since Galderma's Oracea (doxycycline) was launched in 2006. Maraoui said Emrosi offers a "unique treatment option" for patients ...